Although TIE-2 receptor expression itself remains stable during the menstrual cycle [35], our observation of increased ANGPT-1 and ANGPT-2 levels in adenomyosis patients indicates that altered ligand activity, rather than receptor availability, may contribute to aberrant angiogenesis. Here, ANGPT1 is linked to adenomyosis.